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Use of the Short-Form-36 Health Survey to detect a subgroup of
fibromyalgia patients with psychological dysfunction
Abstract
The aim of the present study was to examine the in-depth application of the Short-Form-(SF)-36 Health
Survey to score the general well-being in fibromyalgia syndrome (FS) patients. Quality of life was
evaluated in 12 patients with FS. With respect to mental well-being (social functioning, role limitation
due to emotional health problems, and mental health), two distinguished groups were found concerning
psychological functioning. One group (n = 8) demonstrated psychological dysfunction, whereas the
other (n = 4) showed normal psychological scores. Physical well-being scores (physical functioning,
role limitation due to physical health problems, bodily pain, general health, and vitality) did not differ
between FS patients but were altogether below the normal range. Regarding the psychological scores of
the two groups of patients, SF-36 can be used to differentiate between patients with and without
psychological dysfunction independent of pain. Therefore, we propose that the SF-36 could be of help to
provide the most adequate therapy to achieve an optimal outcome in patients with FS and psychological
disturbances.
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13 Abstract The aim of the present study was to examine the
14 in-depth application of the Short-Form-(SF)-36 Health
15 Survey to score the general well-being in fibromyalgia
16 syndrome (FS) patients. Quality of life was evaluated in 12
17 patients with FS. With respect to mental well-being (social
18 functioning, role limitation due to emotional health problems,
19 and mental health), two distinguished groups were found
20 concerning psychological functioning. One group (n = 8)
21 demonstrated psychological dysfunction, whereas the other
22 (n = 4) showed normal psychological scores. Physical well-
23 being scores (physical functioning, role limitation due to
24 physical health problems, bodily pain, general health, and
25 vitality) did not differ between FS patients but were
26 altogether below the normal range. Regarding the psycho-
27 logical scores of the two groups of patients, SF-36 can be
28 used to differentiate between patients with and without
29 psychological dysfunction independent of pain. Therefore,
30 we propose that the SF-36 could be of help to provide the
31 most adequate therapy to achieve an optimal outcome in
32 patients with FS and psychological disturbances.
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35 Introduction
36 Fibromyalgia syndrome (FS) is a chronic widespread pain
37 condition that affects 1–4% of the population and is
38characterized by diffuse pain in the absence of synovitis or
39myositis [1]. The musculoskeletal examination is unremark-
40able except for tenderness upon palpation of discrete
41anatomical locations termed tender points [2]. Associated
42symptoms include sleep disturbance, fatigue, irritable bowel
43syndrome, cognitive disturbances, and mood disorders [1].
44The patients who fulfill the classification criteria of the
45American College of Rheumatology (ACR) for the diag-
46nosis of FS [3] are not a homogenous group. It has been
47postulated that FS is not a distinct clinical entity [4]. There
48are different subgroups of primary FS. At least three
49different subgroups have been described: one group with
50high pain sensitivity without any associated psychological/
51cognitive factors, a second group which displays moderate
52tenderness and normal mental well-being, and a third group
53in which psychological/cognitive factors may play a major
54role in pain manifestation [4, 5]. There is also growing
55evidence for a substantial lifetime psychiatric comorbidity
56in individuals with FS [6].
57Assessment of patients with FS should therefore not only
58focus on myofascial pain and the search for the tender
59points but also on concomitant affective disorders. Consid-
60ering distinct subgroups, one might be able to provide the
61patients with an adequate individual therapy.
62While postulating different subgroups of FS with possible
63psychiatric comorbidity, an easily applied instrument for the
64differentiation between individuals with and without affective
65distress needs to be found. Subjective information has proven
66to be a useful tool in the assessment of rheumatoid arthritis
67patients [7, 8] as well as in FS patients [9]. Birtane et al. [10]
68found in their study, using SF-36, that patients with FS are
69more severely affected in mental health when compared to
70patients with rheumatoid arthritis. The SF-36 is providing
71information on patients’ physical, functional, emotional, and
72social well-being. Whether using SF-36 helps to distinguish
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73 between patients with and without affective disorders needs
74 to be investigated. We therefore test the hypothesis that SF-
75 36 is a tool to select patients with FS in need of specialized
76 psychological therapy.
77 Materials and methods
78 Patient selection
79 The study was performed in FS patients who presented at
80 the Department of Rheumatology, University Hospital of
81 Zurich, Switzerland. The diagnosis of FS was made
82 according to the ACR classification criteria available for
83 the disease [3]. Twelve patients were prospectively included
84 during the study period. The patients were of sufficient
85 intellectual capacity to fill out the SF-36 and they need to
86 give informed consent to participate in the study. Patients
87 underwent a complete physical examination and specific
88 consultations when needed. Patients with additional sys-
89 temic health disorders, which may have the potential to
90 influence the functional capacity of the patients, were not
91 included in the study. Before the performance of physical
92 examination, demographic characteristics, such as age,
93 gender, height, and weight, and social parameters, such as
94 employment, educational, economical, and marital status of
95 the study participants, were noted.
96 Measurements
97 Health Survey Questionnaire (SF-36)
98 The SF-36 was used to evaluate the quality of life of each
99 FS subject and to distinguish FS patients with and without
100 emotional impairment [11]. All the patients with FS
101 completed the SF-36 questionnaire at the time of their
102 clinical evaluation. The SF-36 consists of 36 items that are
103 employed to calculate scores on eight dimensions: physical
104 functioning, role limitation due to physical health problems,
105 bodily pain, general health, vitality, social functioning, role
106 limitation due to emotional health problems, and mental
107 health. Scores range from 0 to 100, with a higher score
108 indicating a better health-related quality of life. The SF-36
109 questionnaire data are presented as graphs (Fig. 1).
110 Results
111 In analyzing our data, we found two different groups of
112 patients with FS in terms of psychological well-being
113 independent of pain intensity (Fig. 1). Patients with values
114 below 50 were considered as patients with emotional
115 problems. Black bars show an example of the general health
116of the patients with emotional problems and pain (n=8),
117which were showing extensively reduced emotional role, and
118white bars present patients (n=4) with good emotional role
119and pain. Both groups showed similar physical dysfunction.
120Regarding role limitation due to emotional health problems,
121mental health, and social functioning, the data demonstrated
122dysfunction in one distinct group. The physical function,
123bodily pain, and vitality parameters were reduced in both the
124subgroups compared to control group of age-matched US
125healthy women (line).
126Discussion
127Pain and depression may affect the daily life and functional
128activities of the FM patients, which can be measured by the
129SF-36. Our study compared the quality of life of 12 twelve
130patients with FS. Analyzing the scores of the SF-36, we
131found differences in both emotional and mental health and
132social functioning. These findings help to confirm the
133clinical suspicion of different subgroups of patients with
134FS. While one group scored normal psychological results,
135the other showed psychological dysfunction. Differentiating
136the latter subgroup based on responses to the Multidimen-
137sional Pain Inventory study by Thieme et al. [1, 12], nearly
13875% of the patients with FS exhibited anxiety and mood
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Fig. 1 Health survey questionnaire (SF-36) score of fibromyalgia
patients with and without disturbed “role emotional.” White bars
represent the general health score of the patients with normal
emotional status. Black bars show the general health of the patients
with reduced emotional role. The line represents healthy female
reference population [11] in the same age range as the patients. 0 Most
severe failure, 100 most healthy state. Means are given
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139 disorders. Arnold et al. [13] found heightened incidence of
140 FS combined with major mood disorders in families. The
141 high degree of familial aggregation found in the study of
142 Arnold et al. could not be plausibly explained in the
143 absence of genetic factors [14, 15].
144 The results of our study suggest that the SF-36 allows a
145 differentiation of subgroups in FS patients in terms of
146 psychological impairment. Observing the role limitation
147 due to emotional health problems, a clear separation of
148 patients with mood disorders can be seen. Using just one
149 dimension of the SF-36, this differentiation of the sub-
150 groups is possible. Therefore, we conclude that patients
151 with a negative score on role limitation due to emotional
152 health problems need to be treated against psychological
153 dysfunction assuming that there is a mood disorder.
154 Postulating different subgroups in patients with FS, the
155 application of multimodal individualized treatment pro-
156 grams needs consideration in the multifaceted nature of FS.
157 Therefore, examination of FS patients should not only
158 include the search for the tender points but also for the
159 presence of affective disorders. Treatment should aim at
160 physical and emotional well-being. Because of the small
161 number of patients in our study, statistical analysis was not
162 performed. However, the results suggest how important the
163 consideration of the mental health in FS patients may be in
164 regard to their individual therapy regime.
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